JP2021531755A5 - - Google Patents
Info
- Publication number
- JP2021531755A5 JP2021531755A5 JP2021500805A JP2021500805A JP2021531755A5 JP 2021531755 A5 JP2021531755 A5 JP 2021531755A5 JP 2021500805 A JP2021500805 A JP 2021500805A JP 2021500805 A JP2021500805 A JP 2021500805A JP 2021531755 A5 JP2021531755 A5 JP 2021531755A5
- Authority
- JP
- Japan
- Prior art keywords
- igg1
- domain
- linker
- domain monomer
- polypeptide
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862696724P | 2018-07-11 | 2018-07-11 | |
| US62/696,724 | 2018-07-11 | ||
| PCT/US2019/041487 WO2020014542A2 (en) | 2018-07-11 | 2019-07-11 | Compositions and methods related to engineered fc-antigen binding domain constructs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531755A JP2021531755A (ja) | 2021-11-25 |
| JPWO2020014542A5 JPWO2020014542A5 (https=) | 2022-07-15 |
| JP2021531755A5 true JP2021531755A5 (https=) | 2022-07-15 |
Family
ID=69142519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500805A Withdrawn JP2021531755A (ja) | 2018-07-11 | 2019-07-11 | 改変されたＦｃ−抗原結合ドメイン構築物に関する組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210284717A1 (https=) |
| EP (1) | EP3820910A4 (https=) |
| JP (1) | JP2021531755A (https=) |
| KR (1) | KR20210042325A (https=) |
| CN (1) | CN112969717A (https=) |
| AU (1) | AU2019301698A1 (https=) |
| BR (1) | BR112021000393A2 (https=) |
| CA (1) | CA3106254A1 (https=) |
| IL (1) | IL279989A (https=) |
| MX (1) | MX2021000305A (https=) |
| WO (1) | WO2020014542A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202434644A (zh) * | 2023-02-07 | 2024-09-01 | 大陸商上海齊魯製藥研究中心有限公司 | 三特異性抗原結合分子及其應用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5616428B2 (ja) * | 2009-04-07 | 2014-10-29 | ロシュ グリクアート アクチェンゲゼルシャフト | 三価の二重特異性抗体 |
| EP3878964A1 (en) * | 2012-11-27 | 2021-09-15 | Ajou University Industry-Academic Cooperation Foundation | Ch3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof |
| JP2017518965A (ja) * | 2014-05-02 | 2017-07-13 | モメンタ ファーマシューティカルズ インコーポレイテッ | エンジニアリングされたＦｃ構築物に関連する組成物および方法 |
| CN107001482B (zh) * | 2014-12-03 | 2021-06-15 | 豪夫迈·罗氏有限公司 | 多特异性抗体 |
| AU2016252773B2 (en) * | 2015-04-24 | 2022-06-02 | Genentech, Inc. | Multispecific antigen-binding proteins |
| WO2017151971A2 (en) * | 2016-03-02 | 2017-09-08 | Momenta Pharmaceuticals, Inc. | METHODS RELATED TO ENGINEERED Fc CONSTRUCTS |
| BR112018074056A2 (pt) * | 2016-05-23 | 2019-03-06 | Momenta Pharmaceuticals, Inc. | composições e métodos relacionados a construtos de fc manipulados |
| RU2019124709A (ru) * | 2017-01-06 | 2021-02-08 | Момента Фармасьютикалз, Инк. | КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА |
-
2019
- 2019-07-11 WO PCT/US2019/041487 patent/WO2020014542A2/en not_active Ceased
- 2019-07-11 CN CN201980059580.2A patent/CN112969717A/zh active Pending
- 2019-07-11 EP EP19834086.1A patent/EP3820910A4/en not_active Withdrawn
- 2019-07-11 US US17/259,051 patent/US20210284717A1/en not_active Abandoned
- 2019-07-11 BR BR112021000393-2A patent/BR112021000393A2/pt not_active IP Right Cessation
- 2019-07-11 JP JP2021500805A patent/JP2021531755A/ja not_active Withdrawn
- 2019-07-11 KR KR1020217004247A patent/KR20210042325A/ko not_active Withdrawn
- 2019-07-11 MX MX2021000305A patent/MX2021000305A/es unknown
- 2019-07-11 AU AU2019301698A patent/AU2019301698A1/en not_active Abandoned
- 2019-07-11 CA CA3106254A patent/CA3106254A1/en active Pending
-
2021
- 2021-01-06 IL IL279989A patent/IL279989A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019124709A (ru) | КОМПОЗИЦИИ И СПОСОБЫ, СВЯЗАННЫЕ СО СКОНСТРУИРОВАННЫМИ КОНСТРУКЦИЯМИ НА ОСНОВЕ Fc-АНТИГЕНСВЯЗЫВАЮЩЕГО ДОМЕНА | |
| JP2023021974A5 (https=) | ||
| JP2020048564A5 (https=) | ||
| JP2020531438A5 (ja) | Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質 | |
| JP2021534096A5 (https=) | ||
| HRP20181069T1 (hr) | Antagonistička protutijela na il-17 | |
| JP2019525738A5 (https=) | ||
| JP2020508655A5 (https=) | ||
| JP2016533763A5 (ja) | ヒトｐｄ−１に特異的に結合する抗体抗原結合ドメインおよびそれを含む医薬組成物 | |
| JP2018516546A5 (https=) | ||
| JP2009537608A5 (https=) | ||
| JP2019501883A5 (https=) | ||
| JP2021531268A5 (https=) | ||
| JP2017169559A5 (https=) | ||
| JP2018526981A5 (https=) | ||
| RU2009120699A (ru) | Гуманизированные антитела к фактору d и их применения | |
| JP2018507188A5 (https=) | ||
| JP2021520832A5 (https=) | ||
| JP2012501670A5 (https=) | ||
| JP2018522888A5 (https=) | ||
| FI3781200T3 (fi) | Kelatoituneiden radionuklidien vasta-aineita | |
| JP2020514301A5 (https=) | ||
| RU2022108410A (ru) | Терапевтические антитела против лиганда cd40 | |
| JP2021530498A5 (https=) | ||
| JPWO2020160560A5 (https=) |